Found: 12
Select item for more details and to access through your institution.
The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07423-w
- By:
- Publication type:
- Article
Cigarette smoke increases susceptibility of alveolar macrophages to SARS-CoV-2 infection through inducing reactive oxygen species-upregulated angiotensin-converting enzyme 2 expression.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34785-6
- By:
- Publication type:
- Article
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30565-4
- By:
- Publication type:
- Article
Navigating the challenges of invasive pulmonary aspergillosis in lung cancer treatment: a propensity score study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231198454
- By:
- Publication type:
- Article
Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study.
- Published in:
- BMC Pulmonary Medicine, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12890-021-01530-6
- By:
- Publication type:
- Article
Development and validation of a prediction index for recent mortality in advanced COPD patients.
- Published in:
- NPJ Primary Care Respiratory Medicine, 2022, v. 32, n. 1, p. 1, doi. 10.1038/s41533-021-00263-7
- By:
- Publication type:
- Article
Chemotherapy outcomes in EGFR‐TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 19, p. 1857, doi. 10.1111/1759-7714.14930
- By:
- Publication type:
- Article
Improved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 182, doi. 10.1111/1759-7714.14237
- By:
- Publication type:
- Article
First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 3, p. 287, doi. 10.1111/1759-7714.13462
- By:
- Publication type:
- Article
Helicobacter pylori Test-and-Treat Program Can Be Cost-effective to Prevent Gastric Cancer in Taiwanese Adults: Referred to the Nationwide Reimbursement Database.
- Published in:
- Helicobacter, 2015, v. 20, n. 2, p. 114, doi. 10.1111/hel.12185
- By:
- Publication type:
- Article